Pages that link to "Q37597055"

The following pages link to Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina (Q37597055):

Displaying 45 items.

• Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies (Q26782118) (← links)
• The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America (Q28476526) (← links)
• Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain. (Q33162074) (← links)
• Lack of association between blood-based detection of Trypanosoma cruzi DNA and cardiac involvement in a non-endemic area. (Q33908402) (← links)
• Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment (Q33962768) (← links)
• Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease (Q34016698) (← links)
• A field trial of alternative targeted screening strategies for Chagas disease in Arequipa, Peru (Q34131239) (← links)
• In Vivo Antiprotozoal Activity of the Chloroform Extract from Carica papaya Seeds against Amastigote Stage of Trypanosoma cruzi during Indeterminate and Chronic Phase of Infection (Q34234349) (← links)
• Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas (Q34549703) (← links)
• The epidemiological relevance of family study in Chagas disease (Q34607251) (← links)
• Barriers to treatment access for Chagas disease in Mexico (Q35023674) (← links)
• Polyfunctional T cell responses in children in early stages of chronic Trypanosoma cruzi infection contrast with monofunctional responses of long-term infected adults (Q35071204) (← links)
• Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity (Q35333873) (← links)
• Clinical aspects of Chagas disease and implications for novel therapies (Q35676177) (← links)
• Integrated control of Chagas disease for its elimination as public health problem--a review (Q35810731) (← links)
• A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole (Q35810796) (← links)
• Therapy of chagas disease: implications for levels of prevention (Q35864834) (← links)
• Electrocardiographic Abnormalities and Treatment with Benznidazole among Children with Chronic Infection by Trypanosoma cruzi: A Retrospective Cohort Study (Q36012043) (← links)
• Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study (Q36526649) (← links)
• New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients (Q36571807) (← links)
• Putative Role of the Aldo-Keto Reductase from Trypanosoma cruzi in Benznidazole Metabolism (Q36887765) (← links)
• Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina (Q37007518) (← links)
• Towards a paradigm shift in the treatment of chronic Chagas disease. (Q37544885) (← links)
• Transmission of chagas disease (American trypanosomiasis) by food. (Q37770761) (← links)
• Parasitic infections and myositis (Q37924643) (← links)
• Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America (Q38682631) (← links)
• Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses (Q38871286) (← links)
• Quantitative PCR and unconventional serological methods to evaluate clomipramine treatment effectiveness in experimental Trypanosoma cruzi infection. (Q40525658) (← links)
• Analysis of the transmission of Trypanosoma cruzi infection through hosts and vectors (Q40730655) (← links)
• Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease (Q42789311) (← links)
• Prophylaxis and treatment of Chagas disease in renal transplant donor and recipient: case report (Q43155440) (← links)
• Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission (Q43228391) (← links)
• Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole. (Q43584085) (← links)
• Combined treatment with benznidazole and allopurinol in mice infected with a virulent Trypanosoma cruzi isolate from Nicaragua. (Q44302449) (← links)
• Use of clomipramine as chemotherapy of the chronic phase of Chagas disease. (Q46005772) (← links)
• A systems approach to vaccine decision making (Q48031367) (← links)
• Trypanosoma cruzi: death phenotypes induced by ortho-naphthoquinone substrates of the aldo-keto reductase (TcAKR). Role of this enzyme in the mechanism of action of β-lapachone (Q50200648) (← links)
• Development of an ionic-liquid-based dispersive liquid-liquid microextraction method for the determination of antichagasic drugs in human breast milk: Optimization by central composite design (Q50438845) (← links)
• Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy. (Q55438508) (← links)
• Distinct Treatment Outcomes of Antiparasitic Therapy in -Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes (Q57110653) (← links)
• Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease (Q58843435) (← links)
• Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment (Q64247434) (← links)
• Screening of Deceased Organ Donors: No Easy Answers (Q82383996) (← links)
• Benznidazole levels in blood vary with age in rats (Q84310070) (← links)
• Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil (Q93025639) (← links)